Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,008 | 4,590 | 7,721 | 4,252 | 6,089 |
| Receivables | 686 | 1,079 | 4,049 | N/A | N/A |
| Inventories | 22,626 | 22,660 | 22,639 | 22,287 | 17,209 |
| TOTAL | $43,331 | $31,686 | $37,945 | $27,935 | $24,611 |
| Non-Current Assets | |||||
| Investments And Advances | 38 | 38 | 38 | 38 | 38 |
| Intangibles | 9,347 | 9,347 | 9,347 | 9,347 | 9,347 |
| Other Non-Current Assets | 89,539 | 91,470 | 93,062 | 93,619 | 93,681 |
| TOTAL | $98,924 | $100,855 | $102,447 | $103,004 | $103,066 |
| Total Assets | $142,255 | $132,541 | $140,392 | $130,938 | $127,677 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,038 | 9,454 | 11,021 | 13,694 | 10,094 |
| Accrued Expenses | 27,785 | 27,740 | 7,788 | 7,483 | 12,234 |
| Other current liabilities | 15,650 | 17,650 | 18,250 | 22,650 | 28,400 |
| TOTAL | $51,649 | $55,016 | $38,207 | $44,915 | $51,843 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,410 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,647 | 7,515 | 1,855 | 1,509 | 1,181 |
| TOTAL | $14,697 | $8,441 | $8,717 | $8,496 | $8,274 |
| Total Liabilities | $66,347 | $63,456 | $46,924 | $53,410 | $60,116 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,453 | 27,453 | 22,376 | 20,763 | 17,012 |
| Common Shares | 28 | 22 | 22 | 18 | 15 |
| Retained earnings | -277,119 | -268,256 | -247,025 | -238,804 | -230,845 |
| Other shareholders' equity | 9,295 | 7,543 | 13,510 | 9,977 | 2,502 |
| TOTAL | $75,909 | $69,085 | $93,468 | $77,528 | $67,561 |
| Total Liabilities And Equity | $142,255 | $132,541 | $140,392 | $130,938 | $127,677 |